Cite
Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.
MLA
Frouni, Imane, et al. “Effect of the Glycine Transporter 1 Inhibitor ALX-5407 on Dyskinesia, Psychosis-like Behaviours and Parkinsonism in the MPTP-Lesioned Marmoset.” European Journal of Pharmacology, vol. 910, Nov. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2021.174452.
APA
Frouni, I., Belliveau, S., Maddaford, S., Nuara, S. G., Gourdon, J. C., & Huot, P. (2021). Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset. European Journal of Pharmacology, 910, N.PAG. https://doi.org/10.1016/j.ejphar.2021.174452
Chicago
Frouni, Imane, Sébastien Belliveau, Shawn Maddaford, Stephen G. Nuara, Jim C. Gourdon, and Philippe Huot. 2021. “Effect of the Glycine Transporter 1 Inhibitor ALX-5407 on Dyskinesia, Psychosis-like Behaviours and Parkinsonism in the MPTP-Lesioned Marmoset.” European Journal of Pharmacology 910 (November): N.PAG. doi:10.1016/j.ejphar.2021.174452.